ClinicalTrialsFinder
RecruitingNot ApplicableNCT06566352

Different Methods to Minimize Blood Loss During Laparoscopic Myomectomy; A Randomized Controlled Clinical Trial

Sponsor

Zagazig University

Enrollment

60 participants

Start Date

May 1, 2024

Study Type

INTERVENTIONAL

Conditions

Different Methods to Minimize Blood Loss During Laparoscopic Myomectomy

Summary

Laparoscopic myomectomy with temporary bilateral uterine artery occlusion or intramyometrial injection of diluted epinephrine will be important to reduce intraoperative bleeding, time of operation and hospitalization period after laparoscopic myomectomy.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 39 Years

Inclusion Criteria6

  • Women aged from 18 to 39 years.
  • Symptomatizing Women (heavy menstrual bleeding or subfertility).
  • FIGO stage (3-7) by ultrasound.
  • Only uterine corpus fibroid.
  • Up to three fibroids by ultrasound.
  • No previous hormonal treatment.

Exclusion Criteria5

  • Patients with bleeding tendency.
  • Patients who refuse to participate in the study or uncooperative patients.
  • Current pregnancy.
  • Any retroperitoneal surgery at pararectal space.
  • More than one cesarean delivery.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURELaparoscopic myomectomy with intramyometrial injection of diluted epinephrine

intramyometrial injection of epinephrine 1mg diluted in 200mg of NaCl solution

PROCEDUREtraditional laparoscopic myomectomy

traditional laparoscopic myomectomy

PROCEDURElaparoscopic myomectomy with temporary bilateral uterine artery occlusion

Experimental: laparoscopic myomectomy with temporary bilateral uterine artery occlusion

DRUGinjection of epinephrine 1mg diluted in 200mg of NaCl

injection of epinephrine 1mg diluted in 200mg of NaCl

Locations(1)

Zagazig University

Zagazig, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06566352